Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles

Journal of Drugs in Dermatology

Volumn 10, Issue 9, 2011, Pages 982-987

  Brandt, Fredric ^a   Bassichis, Benjamin ^b   Bassichis, Michelle ^c   O'Connell, Christopher ^a   Lin, Xiaoming ^d  

^a Dermatology Research Institute   (United States)

^b Advanced Facial Plastic Surgery Center   (United States)

^c Center for Advanced Clinical Research   (United States)

^d Medicis Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CLINICAL EFFECTIVENESS; DERMIS; ERYTHEMA; FEMALE; GLOBAL AESTHETIC IMPROVEMENT SCALE; HEADACHE; HUMAN; IMPLANTATION; MOUTH; OUTCOME ASSESSMENT; RATING SCALE; SAFETY; SKIN BRUISING; SKIN DISCOMFORT; SKIN SWELLING; SKINFOLD; WRINKLE; WRINKLE SEVERITY RATING SCALE; WRINKLE SEVERITY SCALE;

AGED; COSMETIC TECHNIQUES; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; MIDDLE AGED; PARTICLE SIZE; SEVERITY OF ILLNESS INDEX; SKIN AGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 80053306608     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Weinkle S. Injection techniques for revolumization of the perioral region with hyaluronic acid. J Drugs Dermatol. 2010;9(4):367-371.
2. Agarwal A, Dejoseph L, Silver W. Anatomy of the jawline, neck, and perioral area with clinical correlations. Facial Plast Surg. 2005;21(1):3-10. (Pubitemid 40868924)
3. Carruthers JD, Glogau RG, Blitzer A. Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg. 2008;121(suppl 5):5S-30S.
4. Narins RS, Dayan SH, Brandt FS, Baldwin EK. Persistence and improvement of nasolabial fold correction with nonanimalstabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: Results up to 18 months on two retreatment schedules. Dermatol Surg. 2008;34(suppl 1):2S-8S.
5. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid gel for soft tissue augmentation: A clinical and histological study. Dermatol Surg. 1998;24(12):1317-1325. (Pubitemid 29018221)
6. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-595. (Pubitemid 36702442)
7. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005;115(1):282-289. (Pubitemid 40187829)
8. André P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA-Q-Medical, Sweden) in European countries: A retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18(4):422-425.
9. DeLorenzi C, Weinberg M, Solish N, Swift A. Multicenter study of the efficacy and safety of subcutaneous nonanimal stabilized hyaluronic acid in aesthetic facial contouring: Interim report. Dermatol Surg. 2006;32(2):205-211.
10. Cosmetic Surgery National Data Bank: Statistics 2009. The American Society for Aesthetic Plastic Surgery Web Site. Available at: http://www.surgery.org/sites/default/files/2009stats. pdf. Accessed September 7, 2010.
11. Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008;34(suppl 1):105S-109S.
12. Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: A randomized, evaluator-blinded comparative trial. Dermatol Surg. 2009;35(suppl 2):1653-1660.
13. Beer K, Lupo MP. Making the right choices: Attaining predictable aesthetic results with dermal fillers. J Drugs Dermatol. 2010;9(5):458-465.
14. Restylane [package insert]. Scottsdale, AZ: Medicis Aesthetics, Inc.; 2008.
15. Perlane [package insert]. Scottsdale, AZ: Medicis Aesthetics, Inc.; 2009.
16. Dover JS, Rubin MG, Bhatia AC. Review of the efficacy, durability, and safety data of two nonanimal stabilized hyaluronic acid fillers from a prospective, randomized, comparative, multicenter study. Dermatol Surg. 2009;35(suppl 1):322-331.
17. Weinberg MJ, Solish N. Complications of hyaluronic acid fillers. Facial Plast Surg. 2009;25(5):324-328.
18. Hirsch RJ, Stier M. Complications of soft tissue augmentation. J Drugs Dermatol. 2008;7(9):841-845.
19. Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: Review and technical considerations. Plast Reconstr Surg. 2007;120(suppl 6):41S-54S.